Despite recent advances in immunotherapy and targeted therapy, most patients with non-small-cell lung cancer (NSCLC) continue to have disease progression and develop resistance to current treatments.

Neural stem cells (NSCs) sit at the heart of brain development, lifelong neurogenesis, and the brain’s capacity to respond to injury and disease. Their fate ...

Explore the ultimate guide to automated brain organoid culture workflows and learn how the CellXpress.ai system enables scalable ...

Persistent viral infections pose a unique challenge to the immune system. Prolonged antigen exposure drives T cells into a state of exhaustion — a ...

A new study published in Nature Communications shows that human glial progenitor cells are a promising and safe cell product ...

Long-term RELAZA2 data showed MRD-guided therapy may improve outcomes for AML and MDS patients through earlier intervention.

Scientists have developed a powerful new technique that allows them to observe how individual cells manufacture proteins ...

In the past decade, chimeric antigen receptor (CAR) T cell therapy, which leverages a patient’s engineered immune cells to ...

A new regenerative therapy uses immune cells to reduce liver scarring in cirrhosis patients. In the MATCH clinical trial, ...

China’s artificial embryos are part of an experiment to learn more about how human pregnancies could develop under ...